NCT01593722View on ClinicalTrials.gov

Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis

PHASE4CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

January 31, 2014

Conditions
Loiasis
Interventions
DRUG

Diethylcarbamazine

single dose

DRUG

Ivermectin

single dose

Trial Locations (1)

Unknown

Filariasis and other Tropical Diseases Research Center, Yaoundé

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01593722 - Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis | Biotech Hunter | Biotech Hunter